Production of Pituitary Hormone by Human Pituitary Adenoma is under Autocrine and Paracrine Regulation of Hypothalamic Hormones Secreted from Adenoma Cells

Acta Histochemica et Cytochemica

Volumn 36, Issue 5, 2003, Pages 415-420

  Matsuno, Akira ^a   Nagashima, Tadashi ^a   Katakami, Hideki ^b   Sanno, Naoko ^c   Teramoto, Akira ^c   Takekoshi, Susumu ^d   Osamura, R Yoshiyuki ^d   Kirino, Takaaki ^e   Lloyd, Ricardo V ^f  

^a TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^f MAYO CLINIC   (United States)

Author keywords

Autocrine or paracrine regulation; Hypothalamic hormone; Pituitary adenoma

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS HORMONE; MESSENGER RNA;

AUTOCRINE EFFECT; CELL FUNCTION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; HYPOTHALAMUS; PARACRINE SIGNALING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TUMOR CELL;

EID: 0242492988     PISSN: 00445991     EISSN: None     Source Type: Journal    
DOI: 10.1267/ahc.36.415     Document Type: Review

References (48)

1. Akita, S., Webster, J., Ren, S. G., Takino, H., Said, J., Zand, O. and Melmed, S. (1995) Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J. Clin. Invest 95; 1288-1298.
2. Antoni, F. A. (1993) Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 14; 76-122.
3. Asa, S. L., Kovacs, K., Tindall, G. T., Barrow, D. L., Horvath, E. and Vecsei, P. (1984) Cushing's disease associated with an intrasellar gangliocytoma producing corticotrophin-releasing factor. Ann. Intern. Med. 101; 789-793.
4. Bilezikjian, L. M. and Vale, W. W. (1983) Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3′,5′-monophosphate in cultured anterior pituitary cells. Endocrinology 113; 657-662.
5. Biller, B., Klibanski, A., Koenig, J. and Martin, J. B. (1987) Diagnostic dilemmas in the management of hypothalamic-pituitary-adrenal disorders. Ann. N. Y. Acad. Sci. 512; 338-350.
6. Carey, R. M., Varma, S. K., Drake, C. R. Jr., Thomer, M. O., Kovacs, K., Rivier, J. and Vale, W. (1984) Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. N. Engl. J. Med. 311; 13-20.
7. Engler, D., Redei, E. and Kola, I. (1999) The corticotropin-releasing inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocr. Rev. 20; 460-500.
8. Fjellestad-Paulsen, A., Abrahamsson, P. A., Bjartell, A., Grino, M., Grimelius, L., Hedeland, H. and Falkmer, S. (1988) Carcinoma of the prostate with Cushing's syndrome. A case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissue. Acta Endocrinol. (Copenh) 119; 506-516.
9. Hsu, D. W., Hooi, S. C., Hedley-Whyte, E. T., Strauss, R. M. and Kaplan, L. M. (1991) Co-expression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas. Am. J. Pathol. 138; 897-909.
10. Itoh, J., Matsuno, A., Yamamoto, Y., Kawai, K., Serizawa, A., Watanabe, K., Itoh, Y. and Osamura, R. Y. (2001) Confocal laser scanning microscopic imaging of subcellular organelles, mRNA, protein products, and the microvessel environment. Acta Histochem. Cytochem. 34; 285-297.
11. Jones, P. M., Ghatei, M. A., Steel, J., O'Halloran, D., Gon, G., Legon, S., Burrin, J. M., Leonhardt, U., Polak, J. M. and Bloom, S. R. (1989) Evidence or neuropeptide Y synthesis in the rat anterior pituitary and the influence of thyroid hormone status: comparison with vasoactive intestinal peptide, substance P and neurotensin. Endocrinology 125; 334-341.
12. Joubert (Bression), D., Benlot, C., Lagoguey, A., Gamier, P., Brandi, A. M., Gautron, J. P., Legrand, J. C. and Peillon, F. (1989) Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone. J. Clin. Endocrinol. Metab. 68; 572-577.
13. Kakihara, K., Iijima, N., Naruse, Y., Tanaka, Y., Ibata, Y. and Tanaka, M. (2002) Differential expression of prolactin releasing peptide and tyrosine hydroxylase in fibers derived from the same neurons in the rat. Acta Histochem. Cytochem. 35; 461-470.
14. Leung, D. Y., Hamid, Q., Vottero, A., Szefler, S. J., Surs, W., Minshall, E., Chrousos, G. P. and Klemm, D. J. (1997) Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J. Exp. Med. 186; 1567-1574.
15. Levy, A. and Lightman, S. L. (1992) Growth hormone-releasing hormone transcripts in human pituitary adenomas. J. Clin. Endocrinol. Metab. 74; 1474-1476.
16. Levy, A. and Lightman, S. L. (1993) The pathogenesis of pituitary adenomas. Clin. Endocrinol. (Oxf) 38; 559-570.
17. Lopes, M. B., Gaylinn, B. D., Thomer, M. O. and Stoler, M. H. (1997) Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. Am. J. Pathol. 150; 1885-1891.
18. Makara, G. B., Kiss, A., Lolait, S. J. and Aguilera, G. (1996) Hypothalamic-pituitary corticotroph function after shunting of magnocellular vasopressin and oxytocin to the hypophyseal portal circulation. Endocrinology 137; 580-586.
19. Matsuno, A., Teramoto, A., Takekoshi, S., Utsunomiya, H., Ohsugi, Y., Kishikawa, S., Osamura, R. Y., Kirino, T. and Lloyd, R. V. (1994) Application of biotinylated oligonucleotide probes to the detection of pituitary hormone mRNA using northern blot analysis, in situ hybridization at light and electron microscopic level. Histochem. J. 26; 771-777.
20. Matsuno, A., Teramoto, A., Takekoshi, S., Sanno, N., Osamura, R. Y. and Kirino, T. (1995) Expression of plurihormonal mRNAs in somatotrophic adenomas detected using a nonisotopic in situ hybridization method: comparison with lactotrophic adenomas. Hum Pathol. 26; 272-279.
21. Matsuno, A., Teramoto, A., Takekoshi, S., Sanno, N., Osamura, R. Y. and Kirino, T. (1995) HGH, PRL and ACTH gene expression in clinically non-functioning adenomas detected with nonisotopic in situ hybridization method. Endocr. Pathol. 6; 13-20.
22. Matsuno, A., Sasaki, T., Mochizuki, T., Fujimaki, T., Sanno, N., Osamura, R. Y., Teramoto, A. and Kirino, T. (1996) A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone: An adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization and cell culture. Acta Neurochir. (Wien) 138; 1002-1007.
23. Matsuno, A., Nagashima, T., Osamura, R. Y. and Watanabe, K. (1998) Application of ultrastructural in situ hybridization combined with immunohistochemistry to pathophysiological studies of pituitary cell: Technical review. Acta Histochem. Cytochem. 31; 259-265.
24. Matsuno, A., Katakami, H., Sanno, N., Ogino, Y., Osamura, R. Y., Matsukura, S., Shimizu, N. and Nagashima, T. (1999) Pituitary somatotroph adenoma producing growth hormone-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of growth hormone secretion by GHRH. J. Clin. Endocrinol. Metab. 84; 3241-3247.
25. Matsuno, A., Katakami, H., Nagashima, T., Teramoto, A., Osamura, R. Y. and Kirino, T. (2000) Growth hormone-releasing hormone (GHRH) expression in pituitary somatotroph adenomas, studied by immunohistochemistry and in situ hybridization using catalyzed signal amplification system. Hum. Pathol. 31; 789-794.
26. Oka, H., Kameya, T., Sato, Y., Naritaka, H. and Kawano, N. (1999) Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization. J. Neurooncol. 41; 197-204.
27. Osamura, R. Y., Oda, K., Utsunomiya, H., Inada, K., Umemura, S., Shibuya, M., Katakami, H., Voss, J. W., Mayo, K. E. and Rosenfeld, M. G. (1993) Immunohistochemical expression of pit-1 protein in pituitary glands of human GRF transgenic mice: its relationship with hormonal expressions. Endocr. J. 40; 133-139.
28. Osamura, R. Y., Tahara, S., Kurotani, R., Sanno, N., Matsuno, A. and Teramoto, A. (2000) Contributions of immunohistochemistry and in situ hybridization to the functional analysis of pituitary adenomas. J. Histochem. Cytochem. 48; 445-458.
29. Pagesy, P., Croissandeau, G., Le Dafniet, M., Peillon, F. and Li, J. Y. (1992) Detection of thyrotropin-releasing hormone (TRH) mRNA by the reverse transcription-polymerase chain reaction in the human normal and tumoral anterior pituitary. Biochem. Biophys. Res. Commun. 182; 182-187.
30. Ray, D. W., Ren, S. G. and Melmed, S. (1998) Leukemia inhibitory factor regulates proopiomelanocortin transcription. Ann. N.Y. Acad. Sci. 840; 162-173.
31. Sanno, N., Inada, K., Utsunomiya, H., Umemura, S., Itoh, Y., Matsuno, A., Teramoto, A. and Osamura, R. Y. (1994) Expression of Pit-1 product in human pituitaries: histochemical studies using an antibody against synthetic human Pit-1 protein. Med Sci. Res. 22; 685-687.
32. Sanno, N., Teramoto, A., Matsuno, A., Inada, K., Itoh, J. and Osamura, R. Y. (1994) Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Mol. Pathol. 7; 893-899.
33. Sanno, N., Teramoto, A., Matsuno, A., Takekoshi, S. and Osamura, R. Y. (1995) GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 80; 2518-2522.
34. Sanno, N., Matsuno, A., Itoh, J., Kakimoto, K., Teramoto, A. and Osamura, R. Y. (1996) Combined non-isotopic in situ hybridisation and indirect immunohistochemical analysis of hormone production in the rat pituitary gland. J. Clin. Pathol.: Mol. Pathol. 49; M57-M60.
35. Sanno, N., Teramoto, A., Matsuno, A., Itoh, J., Takekoshi, S. and Osamura, R. Y. (1996) In situ hybridization analysis of Pit-I mRNA and hormonal production in human pituitary adenomas. Acta Neuropathol. (Berl) 91; 263-268.
36. Sanno, N., Teramoto, A., Matsuno, A., Takekoshi, S., Itoh, J. and Osamura, R. Y. (1996) Expression of Pit-1 and estrogen receptor messenger RNA in prolactin-producing pituitary adenomas. Mod Pathol. 9; 526-533.
37. Sanno, N., Teramoto, A., Matsuno, A. and Osamura, R. Y. (1996) Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Arch. Pathol. Lab. Med. 120; 73-77.
38. Sanno, N., Teramoto, A., Sugiyama, M., Matsuno, A., Takumi, I., Tahara, S. and Osamura, R. Y. (1998) Expression of Pit-1 mRNA and activin/inhibin subunits in clinically nonfunctioning pituitary adenomas. Horm. Res. 50; 11-17.
39. Sanno, N., Tahara, S., Kurotani, R., Matsuno, A., Teramoto, A. and Osamura, R. Y. (2001) Cytochemical and molecular biological aspects of the pituitary and pituitary adenomas: cell differentiation and transcription factors. Prog. Histochem. Cytochem. 36; 263-299.
40. Schteingart, D. E., Lloyd, R. V., Akil, H., Chandler, W. F., Ibarra-Perez, G., Rosen, S. G. and Ogletree, R. (1986) Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion. J Clin. Endocrinol. Metab. 63; 770-775.
41. Spada, A., Elahi, F. R., Arosio, M., Sartorio, A., Guglielmino, L., Vallar, L. and Faglia, G. (1987) Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly. J. Clin. Endocrinol. Metab. 64; 585-591.
42. Spada, A. and Lania, A. (1996) Hormone receptors in pituitary adenomas. In "Pituitary Adenomas", ed. by A. M. Landolt, M. L. Vance and P. L. Reilly, Churchill Livingstone, New York, pp. 59-71.
43. Stenzel-Poore, M. P., Cameron, V. A., Vaughan, J., Sawchenko, P. E. and Vale, W. (1992) Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130; 3378-3386.
44. Thapar, K., Kovacs, K., Stefaneanu, L., Scheithauer, B., Killinger, D. W., Lloyd, R. V., Smyth, H. S., Barr, A., Thomer, M. O., Gaylinn, B. and Laws, E. R. Jr. (1997) Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior. Am. J. Pathol. 151; 769-784.
45. Umemura, S., Oda, K., Utsunomiya, H., Sanno, N., Itoh, J., Katakami, H. and Osamura, R. Y. (1995) Immunohistochemical characterization of "hyperplasia-adenoma sequence" in the pituitaries of transgenic mice expressing a human growth hormone-releasing factor gene. Tokai J. Exp. Clin. Med. 20; 71-79.
46. Vrontakis, M. E., Sano, T., Kovacs, K. and Friesen, H. G. (1990) Presence of galanin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary. J. Clin. Endocrinol. Metab. 70; 747-751.
47. Wakabayashi, I., Inokuchi, K., Hasegawa, O., Sugihara, H. and Minami, S. (1992) Expression of growth hormone (GH)-releasing factor gene in GH-producing pituitary adenoma. J. Clin. Endocrinol. Metab. 74; 357-361.
48. Xu, B., Sano, T., Yamada, S., Li, C. C. and Hirokawa, M. (2000) Expression of corticotropin-releasing hormone messenger ribonucleic acid in human pituitary corticotroph adenomas associated with proliferative potential. J. Clin. Endocrinol. Metab. 85; 1220-1225.